Categorizing receptor-signaling pathways with FK 506 and rapamycin.
Hultsch
T
T
Allergic Diseases Section, National Institutes of Health, Bethesda, MD 20892.
Hohman
R J
RJ
D000818:Animals; D002352:Carrier Proteins / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008024:Ligands; D011090:Polyenes / Q000494:pharmacology*; D011971:Receptors, Immunologic / Q000187:drug effects / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects*; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*; D022021:Tacrolimus Binding Proteins
D002352:Carrier Proteins; D007166:Immunosuppressive Agents; D008024:Ligands; D011090:Polyenes; D011971:Receptors, Immunologic; D022021:Tacrolimus Binding Proteins; D020123:Sirolimus; D016559:Tacrolimus